Trial intelligence / Profile preview

PVA: Prevenar Vaccination in Arthritis Patients

NCT00828997Phase 4Completed

Sponsor
Region Skåne
Start
Aug 2008
Primary completion
Jan 2018
Modality
Split/Subunit Vaccines
Countries
1
01

Overview

A Phase 4 trial of pneumococcal 7-valent conjugate vaccine in pneumococcal infection, sponsored by Region Skåne. Started Aug 2008; status: completed.

02

Drugs

pneumococcal 7-valent conjugate vaccine
03

Conditions

pneumococcal infection

Beyond the preview

Go deeper on NCT00828997.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00828997.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call